BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6753851)

  • 1. Immune complexes in progressive systemic sclerosis (scleroderma).
    Seibold JR; Medsger TA; Winkelstein A; Kelly RH; Rodnan GP
    Arthritis Rheum; 1982 Oct; 25(10):1167-73. PubMed ID: 6753851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating immune complexes in patients with progressive systemic sclerosis.
    Siminovitch K; Klein M; Pruzanski W; Wilkinson S; Lee P; Yoon SJ; Keystone E
    Arthritis Rheum; 1982 Oct; 25(10):1174-9. PubMed ID: 6753852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune complexes in systemic sclerosis; detection by C1q binding, K-cell inhibition and Raji cell radioimmunoassays.
    Hughes P; Cunningham J; Day M; Fitzgerald JC; French MA; Wright JK; Rowell NR
    J Clin Lab Immunol; 1983 Mar; 10(3):133-8. PubMed ID: 6601718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating immune complexes in mixed connective tissue disease.
    Halla JT; Volanakis JE; Schrohenloher RE
    Arthritis Rheum; 1979 May; 22(5):484-9. PubMed ID: 375940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cryoglobulinemia and circulating immune complexes in progressive systemic sclerosis.
    Malaviya AN; Rajagopalan P; Gupta S; Taneja RL
    Indian J Med Res; 1980 Sep; 72():359-64. PubMed ID: 6970181
    [No Abstract]   [Full Text] [Related]  

  • 6. Circulating immune complexes in eosinophilic fasciitis.
    Seibold JR; Rodnan GP; Medsger TA; Winkelstein A
    Arthritis Rheum; 1982 Oct; 25(10):1180-5. PubMed ID: 6982714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum immune complexes in systemic sclerosis: relationship with precipitating nuclear antibodies.
    French MA; Harrison G; Penning CA; Cunningham J; Hughes P; Rowell NR
    Ann Rheum Dis; 1985 Feb; 44(2):89-92. PubMed ID: 3919660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune complexes in rheumatoid arthritis sera and synovial fluids: a comparison of three methods.
    Halla JT; Volanakis JE; Schrohenloher RE
    Arthritis Rheum; 1979 May; 22(5):440-8. PubMed ID: 444313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative studies of the interaction of 3H-dsDNA/anti-DNA immune complexes with complement: comparison and evaluation of the Raji cell, the solution phase C1Q, and the red blood cell linked complement fixation radioimmunoassays.
    Taylor RP; Andrews BS; Morley KW; Conlon T
    Rheumatol Int; 1981; 1(1):29-34. PubMed ID: 6981180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The complement fixing ability of putative circulating immune complexes in rheumatoid arthritis and its relationship to extra-articular disease.
    Bourke BE; Moss IK; Mumford P; Horsfall A; Maini RN
    Clin Exp Immunol; 1982 Jun; 48(3):726-32. PubMed ID: 6981475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiopulmonary manifestations of progressive systemic sclerosis: associations with circulating immune complexes and fluorescent antinuclear antibodies.
    Pisko E; Gallup K; Turner R; Parker M; Nomeir AM; Box J; Davis J; Box P; Rothberger H
    Arthritis Rheum; 1979 May; 22(5):518-23. PubMed ID: 375941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding characteristics of three complement dependent assays for the detection of immune complexes in human serum.
    Krieger G; Kneba M; Bolz I; Volling P; Wessels J; Nagel GA
    J Clin Lab Immunol; 1985 Nov; 18(3):129-34. PubMed ID: 3878887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune complexes and antinuclear, antinucleolar, and anticentromere antibodies in scleroderma.
    Chen ZY; Virella G; Tung HE; Ainsworth SK; Silver RM; Wang AC; LaVia MF; Maricq HR; Dobson RL
    J Am Acad Dermatol; 1984 Sep; 11(3):461-7. PubMed ID: 6237134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pitfalls in the methodology for detection of immune complexes.
    Heimer R; Per S
    Surv Immunol Res; 1982; 1(1):109-16. PubMed ID: 6195708
    [No Abstract]   [Full Text] [Related]  

  • 15. [Antinuclear antibodies, complement and circulating immune complexes in scleroderma].
    Cárdenas Ortega A; Mejía Arregui S; Orozco Medina H; Arroyave CM
    Alergia; 1981 Jul; 28(3):111-20. PubMed ID: 7036785
    [No Abstract]   [Full Text] [Related]  

  • 16. Lack of activation of C1, despite circulating immune complexes detected by two C1q methods, in patients with rheumatoid arthritis.
    Hack CE; Eerenberg-Belmer AJ; Lim UG; Haverman J; Aalberse RC
    Arthritis Rheum; 1984 Jan; 27(1):40-8. PubMed ID: 6318777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reactivity of low molecular weight material in cellular immune complex assays.
    Cooper KM; Moore M
    Clin Exp Immunol; 1983 May; 52(2):407-16. PubMed ID: 6602679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C1q binding and Raji immune complex assays: a comparison using defined immunoglobulin aggregates.
    Jones DB; Goulding NJ; Casey CR; Gallagher PJ
    J Immunol Methods; 1982 Sep; 53(2):201-8. PubMed ID: 6982945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum antinuclear antibodies in progressive systemic sclerosis (scleroderma).
    Rothfield NF; Rodnan GP
    Arthritis Rheum; 1968 Oct; 11(5):607-17. PubMed ID: 4176069
    [No Abstract]   [Full Text] [Related]  

  • 20. C1q-latex assay for immune complexes. Complexes that react with both C1q and monoclonal rheumatoid factor in lupus erythematosus and lung cancer.
    Medof ME
    J Lab Clin Med; 1982 May; 99(5):678-92. PubMed ID: 6978370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.